MAGT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.171600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.958000E-01
Normal-vs-Stage2
4.916400E-01
Normal-vs-Stage3
7.692800E-01
Normal-vs-Stage4
1.662190E-01
Stage1-vs-Stage2
8.127400E-01
Stage1-vs-Stage3
2.862800E-01
Stage1-vs-Stage4
1.634780E-01
Stage2-vs-Stage3
2.500800E-01
Stage2-vs-Stage4
2.730400E-01
Stage3-vs-Stage4
9.482200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.270800E-01
Normal-vs-AfricanAmerican
1.934650E-01
Normal-vs-Asian
9.378400E-01
Caucasian-vs-AfricanAmerican
1.188180E-01
Caucasian-vs-Asian
1.825610E-01
AfricanAmerican-vs-Asian
5.498400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.442000E-01
Normal-vs-Female
4.765000E-01
Male-vs-Female
9.879800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.249600E-01
Normal-vs-Age(41-60Yrs)
1.574040E-01
Normal-vs-Age(61-80Yrs)
7.435200E-01
Normal-vs-Age(81-100Yrs)
6.967200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.816830E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.075400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.569400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.812200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.071800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.539800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.155000E-01
Normal-vs-Daily Drinker
8.096600E-01
Normal-vs-Weekly Drinker
7.942800E-01
Normal-vs-Occasional Drinker
2.291800E-01
Normal-vs-Social Drinker
5.854200E-01
Non Drinker-vs-Daily Drinker
8.570600E-01
Non Drinker-vs-Weekly Drinker
9.113000E-01
Non Drinker-vs-Occasional Drinker
2.814500E-02
Non Drinker-vs-Social Drinker
6.773200E-01
Daily Drinker-vs-Weekly Drinker
9.664600E-01
Daily Drinker-vs-Occasional Drinker
4.013500E-02
Daily Drinker-vs-Social Drinker
6.094000E-01
Weekly Drinker-vs-Occasional Drinker
7.685900E-02
Weekly Drinker-vs-Social Drinker
6.692400E-01
Occasional Drinker-vs-Social Drinker
1.402560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.496800E-01
Normal-vs-Grade 2
6.960800E-01
Normal-vs-Grade 3
6.355600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.432400E-01
Grade 1-vs-Grade 3
1.033830E-01
Grade 1-vs-Grade 4
4.496800E-01
Grade 2-vs-Grade 3
1.961970E-01
Grade 2-vs-Grade 4
6.960800E-01
Grade 3-vs-Grade 4
6.355600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.922600E-01
Normal-vs-NonDiabetic
5.304600E-01
Diabetic-vs-NonDiabetic
2.941800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.722000E-01
Normal-vs-NoPancreatitis
5.800200E-01
Pancreatitis-vs-NoPancreatitis
5.258600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.125000E-01
Normal-vs-N1
4.494400E-01
N0-vs-N1
1.057970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.829400E-01
Normal-vs-TP53-NonMutant
5.480400E-01
TP53-Mutant-vs-TP53-NonMutant
1.097910E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
